サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1515444

ゲノムバイオマーカー市場：タイプ別、適応疾患別、検証別、エンドユーザー別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Genomic Biomarker Market, By Type, By Disease Indication, By Validation, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ゲノムバイオマーカー市場：タイプ別、適応疾患別、検証別、エンドユーザー別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ゲノムバイオマーカー市場規模は2023年に76億8,420万米ドルとなり、2024年から2032年にかけてCAGR 18.20％で拡大

ゲノムバイオマーカー市場- 市場力学

がん罹患率の増加が市場成長を促進

肺がん、前立腺がん、卵巣がん、乳がんなど、さまざまながんの有病率が上昇していることから、ゲノムバイオマーカー市場の需要は増加すると予想されます。臓器システムと疾患をターゲットにすることは、ヒトの健康におけるバイオマーカーの目標です。特に、バイオマーカーは、治療、クリティカルケア、疾患ベースの診断につながる医療処置において、ますます一般的になりつつあります。がんや心血管疾患などの慢性疾患の発見と管理を改善するために、遺伝子バイオマーカーの必要性が世界中で高まっています。このため、予測期間中にゲノムバイオマーカー市場の需要が増加します。

ゲノムバイオマーカー市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約18.20%のCAGRで毎年成長すると予測されています。

市場セグメンテーションに基づくと、予測バイオマーカーカテゴリが2023年に最大の市場シェアを示すと予測されました。

疾患別適応症では、2023年にがんカテゴリーが主要なタイプでした。

エンドユーザーセグメンテーションに基づくと、2023年には診断カテゴリーが主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

ゲノムバイオマーカー市場-セグメンテーション分析：

世界のゲノムバイオマーカー市場は、タイプ、適応疾患、バリデーション、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプに基づいて2つのカテゴリーに分けられる：予測バイオマーカーと予後バイオマーカーです。予測バイオマーカーのカテゴリーが市場を独占しています。同分野が優位に立つ理由は、予測バイオマーカーが治療前データまたはベースラインデータであり、患者が特定の治療から恩恵を受ける可能性または恩恵を受けない可能性を示すからです。特定の治療薬を開発する際には、コンパニオンバイオマーカーとして予測バイオマーカーが選択されることが多いです。腫瘍学における一般的な例としては、乳がん細胞で細胞増殖をもたらす成長因子タンパク質Her-2の過剰発現を特定できれば、トラスツズマブ（ハーセプチン）の投与時期を予測するバイオマーカーとして使用される可能性があります。乳がん患者にとって、この薬はHer-2の作用をブロックします。そのため、予測バイオマーカーの必要性が高まっています。前述の主張を踏まえると、予測期間中、市場セグメントは最大の市場シェアを占めると推察されます。

同市場は、適応疾患に基づいて以下のカテゴリーに分類される：がん、心血管疾患、神経疾患、腎疾患、その他です。がん領域のカテゴリーが市場を独占しており、予測期間中もその優位性を維持するとみられます。世界のがん患者数の拡大と、バイオマーカーアプローチにおける技術的躍進の増加が、大きな伸びの要因となっています。近年、リスク評価、予測判定、鑑別診断のためのスクリーニング、がんの経過追跡、治療反応予測など、腫瘍学におけるゲノムバイオマーカーの可能な用途が数多く見られるようになった。世界保健機関（WHO）によれば、がんは世界で2番目に多い死因であり、その70％は中低所得国で発生しています。さらに、WHOの推計によると、2018年に世界で報告されたがんの死亡者数は960万人、新規症例数は1,810万人でした。

ゲノムバイオマーカー市場-地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

予測期間中、北米がゲノムバイオマーカーの世界市場で最大のシェアを占めると予想されています。同地域の食生活や生活様式の変化によって慢性疾患の発生率が高まっていることが、同市場の支配を確実なものにしています。ゲノムバイオマーカー市場は、製薬業界による技術利用の増加の結果として成長しました。ゲノムバイオマーカー市場は、米国、カナダなどの国々で実施されている研究開発イニシアチブの増加の結果として上昇すると予想されます。

また、ゲノムバイオマーカー市場は、アジア太平洋地域が予測期間中に世界で最も速い速度で拡大すると予測されています。この地域での市場拡大に最も貢献していると予想される国は、中国、日本、韓国、インドです。公的機関も民間企業も医薬品部門の発展に多額の資金を投入していることが、アジア太平洋市場の拡大を支えています。アジア太平洋地域の市場拡大は、ヘルスケア分野の進歩に関連する様々な遺伝子検査イニシアティブや調査への重点の高まりによって促進されると予測されます。

ゲノムバイオマーカー市場-競合情勢：

ゲノムバイオマーカー市場の主要企業には、Thermo Fisher Scientific（米国）、F. Hoffmann-La Roche Ltd（スイス）、Myriad Genetics, Inc（米国）、Eurofins Scientific（ルクセンブルク）、QIAGEN（ドイツ）などがあります。その他の戦略としては、パートナー間の戦略的提携、相互契約、パートナーシップに関する動向や分析が挙げられます。地理的プレゼンスを高めるため、主要企業は新製品リリースのための最先端戦略を実施しています。

目次

第1章 ゲノムバイオマーカー市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ゲノムバイオマーカーの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ゲノムバイオマーカー産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ゲノムバイオマーカー市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ゲノムバイオマーカー市場情勢

  • ゲノムバイオマーカー市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ゲノムバイオマーカー市場- タイプ別

  • 概要
    • セグメントシェア分析
    • 予測バイオマーカー
    • 予後バイオマーカー

第8章 ゲノムバイオマーカー市場- 疾患適応症別

  • 概要
    • セグメントシェア分析
    • 腫瘍学
    • 心血管疾患
    • 神経疾患
    • 腎疾患
    • その他

第9章 ゲノムバイオマーカー市場- 検証別

  • 概要
    • セグメントシェア分析
    • 分析検証
    • 臨床検証
    • 臨床的有用性

第10章 ゲノムバイオマーカー市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 診断
    • 研究ラボ
    • 病院
    • その他

第11章 ゲノムバイオマーカー市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- ゲノムバイオマーカー業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific（US）
    • F. Hoffmann-La Roche Ltd（Switzerland）
    • Eurofins Scientific（Luxembourg）
    • FOUNDATION MEDICINE, INC.（US）
    • QIAGEN（Germany）
    • Myriad Genetics, Inc（US）
    • Bio-Rad Laboratories, Inc.（US）
    • MedGenome（India）
    • Sema4（US）
    • GENOME LIFE SCIENCES（India）
    • Almac Group（UK）
    • Creative Diagnostics（US）
    • Quanterix（US）
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Genomic Biomarker Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Genomic Biomarker Market, by Type 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Disease Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Indication
  • TABLE Global Genomic Biomarker Market, by Disease Indication 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Validation Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Validation
  • TABLE Global Genomic Biomarker Market, by Validation 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Genomic Biomarker Market, by End User 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Genomic Biomarker Market, by Region 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Genomic Biomarker Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Disease Indication segment market share analysis, 2023 & 2032
  • FIGURE Disease Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Validation segment market share analysis, 2023 & 2032
  • FIGURE Validation segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Genomic Biomarker Market share and leading players, 2023
  • FIGURE Europe Genomic Biomarker Market share and leading players, 2023
  • FIGURE Asia Pacific Genomic Biomarker Market share and leading players, 2023
  • FIGURE Latin America Genomic Biomarker Market share and leading players, 2023
  • FIGURE Middle East and Africa Genomic Biomarker Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Germany Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Genomic Biomarker Market share analysis by country, 2023
  • FIGURE India Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Brazil Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Saudi Arabia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3172

REPORT HIGHLIGHT

Genomic Biomarker Market size was valued at USD 7,684.2 Million in 2023, expanding at a CAGR of 18.20% from 2024 to 2032.

Genomic biomarkers are characteristics of DNA and RNA that are used to characterize diseases, choose treatments, and provide diagnostic information. Genomic biomarkers reflect pathological and physiological processes, as well as the reaction of the organism to treatment. One gene, a collection of genes, or the entire genome can have molecular alterations discovered by genomic biomarker testing. There may or may not be substantial supporting evidence for a connection between a genetic biomarker and the risk of contracting a disease. The clinical validity and usefulness of genomic biomarkers are influenced by two factors: genetic epidemiology data and functional laboratory assessments.

Genomic Biomarker Market- Market Dynamics

Growing Cancer Prevalence to Propel Market Growth

The market demand for genomics biomarkers is expected to increase due to the rising prevalence of various cancers, including lung, prostate, ovarian, and breast cancer. Targeting organ systems and diseases is the goal of biomarkers in human health. In particular, biomarkers are becoming more and more common in medical procedures that lead to therapy, critical care, and disease-based diagnosis. There is a growing need for genetic biomarkers worldwide in order to improve the detection and management of chronic illnesses, including cancer and cardiovascular disease. This leads to an increase in the market's demand for genomics biomarkers during the projected term.

Genomic Biomarker Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 18.20% over the forecast period (2024-2032)

Based on type segmentation, the predictive biomarkers category was predicted to show maximum market share in the year 2023

Based on disease indication segmentation, the oncology category was the leading type in 2023

Based on end user segmentation, the diagnostic category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Genomic Biomarker Market- Segmentation Analysis:

The Global Genomic Biomarker Market is segmented on the basis of Type, Disease Indication, Validation, End User, and Region.

The market is divided into two categories based on type: Predictive Biomarkers and Prognostic Biomarkers. The predictive biomarkers category dominates the market. The reason the segment benefits is that predictive biomarkers are pretreatment or baseline data that indicate a patient's likelihood of benefiting or not from a particular treatment. When creating a particular therapeutic drug, a predictive biomarker is often selected as a companion biomarker. A common example in oncology is a biomarker that might be used to forecast when to administer trastuzumab (Herceptin) if it can identify the overexpression of the growth factor protein Her-2, which gives rise to cell proliferation in breast cancer cells. For patients with breast cancer, this medication blocks the actions of Her-2. Thus, the need for predictive biomarkers has grown as a result. Given the aforementioned claims, it can be inferred that over the forecast period, the market segment will have the greatest market share.

The market is divided into the following categories based on disease indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. The expanding number of cancer patients worldwide and the increasing technological breakthroughs in biomarker approaches are responsible for the significant stake. Recent years have seen a number of possible uses for genomic biomarkers in oncology, including risk assessment, predictive determination, screening for differential diagnoses, tracking the course of cancer, and therapy response prediction. As per the World Health Organization (WHO), cancer ranks as the second most common cause of death worldwide, taking into consideration 70% of fatalities in low- and middle-income nations. Additionally, according to WHO estimates, there were 9.6 million cancer deaths and 18.1 million new cases of cancer reported worldwide in 2018.

Genomic Biomarker Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for genomic biomarker. The increasing incidence of chronic illnesses brought on by the region's shifting dietary and lifestyle patterns will ensure its domination. The market for genomics biomarkers grew as a result of the pharmaceutical industry's increased use of technology. The genomic biomarker market is expected to rise as a result of increased research and development initiatives being implemented in nations like the United States, Canada, etc.

In addition, the genomic biomarker market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The countries that are anticipated to have contributed the most to the market's expansion in the area are China, Japan, South Korea, and India. The significant sums of money that both public and private organizations have invested in the advancement of the pharmaceutical sector support the expansion of the Asia Pacific market. The market's expansion in Asia Pacific is anticipated to be fueled by the growing emphasis on various genetic testing initiatives and research related to the advancement of the healthcare sector.

Genomic Biomarker Market- Competitive Landscape:

Key players in the Genomic Biomarkers market include, Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Myriad Genetics, Inc (U.S.), Eurofins Scientific (Luxembourg), and QIAGEN (Germany), among others. One or more of the growth tactics highlighted is mergers and acquisitions; other strategies include trends and analysis regarding strategic collaboration among partners, mutual agreements, and partnerships. To increase their geographic presence, the major firms are implementing cutting-edge strategies for new product releases.

Recent Developments:

May 2023: The UK MHRA and Genomics England jointly stated that they have formed a joint venture to develop cutting-edge resources to comprehend how a person's genetic composition affects the safety of medications.

May 2023: The announcement was made by Kyoto University, Fujistsu, and Chordia Therapeutics regarding their strategic partnership to begin an AI trial aimed at identifying biomarkers for novel cancer treatments. These findings have led to the collaboration's goal of developing novel cancer therapies that are tailored to each patient.

October 2022: Launching its first commercial product, Biofidelity of North Carolina said that it is funding $23 million to maintain its ASPYRE-Lung diagnostic assay for lung cancer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC BIOMARKER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific (U.S.)

F. Hoffmann-La Roche Ltd (Switzerland)

Eurofins Scientific (Luxembourg)

FOUNDATION MEDICINE, INC. (U.S.)

QIAGEN (Germany)

Myriad Genetics, Inc (U.S.)

Bio-Rad Laboratories, Inc. (U.S.)

MedGenome (India)

Sema4 (U.S.)

GENOME LIFE SCIENCES (India)

Almac Group (U.K.)

Creative Diagnostics (U.S.)

Quanterix (U.S.)

Others

GLOBAL GENOMIC BIOMARKER MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Predictive Biomarkers
  • Prognostic Biomarkers

GLOBAL GENOMIC BIOMARKER MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Renal Disorders
  • Others

GLOBAL GENOMIC BIOMARKER MARKET, BY VALIDATION- MARKET ANALYSIS, 2019 - 2032

  • Analytical Validation
  • Clinical Validation
  • Clinical Utility

GLOBAL GENOMIC BIOMARKER MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Diagnostic
  • Research Laboratories
  • Hospitals
  • Others

GLOBAL GENOMIC BIOMARKER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomic Biomarker Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomic Biomarker Market Snippet by Type
    • 2.1.2. Genomic Biomarker Market Snippet by Disease Indication
    • 2.1.3. Genomic Biomarker Market Snippet by Validation
    • 2.1.4. Genomic Biomarker Market Snippet by End User
    • 2.1.5. Genomic Biomarker Market Snippet by Country
    • 2.1.6. Genomic Biomarker Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomic Biomarker Key Market Trends

  • 3.1. Genomic Biomarker Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomic Biomarker Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomic Biomarker Market Opportunities
  • 3.4. Genomic Biomarker Market Future Trends

4. Genomic Biomarker Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomic Biomarker Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genomic Biomarker Market Landscape

  • 6.1. Genomic Biomarker Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomic Biomarker Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Predictive Biomarkers
    • 7.1.3. Prognostic Biomarkers

8. Genomic Biomarker Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Cardiovascular Diseases
    • 8.1.4. Neurological Diseases
    • 8.1.5. Renal Disorders
    • 8.1.6. Others

9. Genomic Biomarker Market - By Validation

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Validation, 2023 & 2032 (%)
    • 9.1.2. Analytical Validation
    • 9.1.3. Clinical Validation
    • 9.1.4. Clinical Utility

10. Genomic Biomarker Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Diagnostic
    • 10.1.3. Research Laboratories
    • 10.1.4. Hospitals
    • 10.1.5. Others

11. Genomic Biomarker Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Genomic Biomarker Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Genomic Biomarker Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Genomic Biomarker Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Genomic Biomarker Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Genomic Biomarker Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Genomic Biomarker Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific (U.S.)
    • 12.2.2. F. Hoffmann-La Roche Ltd (Switzerland)
    • 12.2.3. Eurofins Scientific (Luxembourg)
    • 12.2.4. FOUNDATION MEDICINE, INC. (U.S.)
    • 12.2.5. QIAGEN (Germany)
    • 12.2.6. Myriad Genetics, Inc (U.S.)
    • 12.2.7. Bio-Rad Laboratories, Inc. (U.S.)
    • 12.2.8. MedGenome (India)
    • 12.2.9. Sema4 (U.S.)
    • 12.2.10. GENOME LIFE SCIENCES (India)
    • 12.2.11. Almac Group (U.K.)
    • 12.2.12. Creative Diagnostics (U.S.)
    • 12.2.13. Quanterix (U.S.)
    • 12.2.14. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us